You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Merck
Baxter
McKesson
Dow
Boehringer Ingelheim
AstraZeneca

Last Updated: October 28, 2020

DrugPatentWatch Database Preview

Litigation for ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

US Court Litigation for ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER

Patent Case Name Docket Date Filed Date Terminated Cause Court Jury Demand Link To Docket
6,310,094   Start Trial   Start Trial 2013-10-18 2017-06-28 35:271 Patent Infringement District Court, D. New Jersey Defendant   Start Trial
6,310,094   Start Trial   Start Trial 2013-10-18 2016-02-22 35:271 Patent Infringement District Court, D. New Jersey Defendant   Start Trial
6,310,094   Start Trial   Start Trial 2014-11-12 2016-04-20 35:271 Patent Infringement District Court, D. New Jersey None   Start Trial
6,528,540   Start Trial   Start Trial 2013-10-18 2017-06-28 35:271 Patent Infringement District Court, D. New Jersey Defendant   Start Trial
>Patent >Case Name >Docket >Date Filed >Date Terminated >Cause >Court >Jury Demand >Link To Docket

Patent Trial and Appeal Board Cases for ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER

Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
6,310,094 Mylan Pharmaceuticals Inc.   Start Trial 2015-11-19 11-19-2015 Baxter International Inc. Inter partes review   Start Trial 04-27-2016 Jie Lui   Start Trial
6,528,540 Mylan Pharmaceuticals Inc.   Start Trial 2015-11-19 11-19-2015 Baxter International Inc. Inter partes review   Start Trial 04-27-2016 Jie Liu   Start Trial
>Patent >Petitioner >Status >Filing Date >Accorded Filing Date >Patent Owner >Trial Type >Trial Number >Decision Date >Inventor >Document Download

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
McKesson
McKinsey
Moodys
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.